A Tennessee man’s $70 million Risperdal award will stand, and the case could be eligible for punitive damages as well. This was the verdict handed down by a Pennsylvania appeals court after Johnson & Johnson appealed the initial jury award and attempted to have the verdict reversed.
The loss of the appeal alone would be bad enough news for Johnson & Johnson and its Janssen Pharmaceuticals unit. However, with ...
continue reading...